Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Rúa do Vidro 117D, Parcelas 3-6, Lugo, 27003, ES
Treatment for hemophilia A remains a significant unmet medical need.
By: Patrick Lavery
New programs combine rapid microbiology testing and NGS characterization to shorten biologics development timelines.
By: Charlie Sternberg
Small Molecules. ADCs. Nucleic Acid Chemistry.
Released By Cohance Lifesciences
The agreement extends manufacturing commitments through 2033 and pushes Samsung Biologics’ cumulative contract value above $21.9 billion.
Formulation, manufacturing and delivery strategies for high-dose biologics administered subcutaneously.
By: Jim Huang, Shaukat Ali
Independent testing shows barrier labels help protect biologics and biosimilars.
WuXi Biologics gains non-exclusive access to selected HiCB platform technologies.
Expanded collaboration deploys Genedata Biologics across Abcam’s global R&D sites to accelerate antibody development and AI-enabled innovation.
New benchmark study explores trends and challenges in bioconjugate and ADC development, from linker-payload chemistry to CDMO selection criteria.
Released By Lonza
Phase 1 study will evaluate TLN-121 with Roche’s glofitamab and mosunetuzumab in patients with B-cell lymphomas.
The agreement covers commercial manufacturing and supply of 20+ sterile injectables, biologics and topical products across key global markets.
Genentech will have license exclusivity, while DualityBio will lead discovery and early clinical development.
Customers can engage Cytovance for analytical method development, transfer, qualification, validation, product characterization, release testing, stability studies, and storage.
New facilities boost small-molecule API, HPAPI, and ADC payload manufacturing capacity.
The acquisition supports Piramal Pharma’s biologics strategy and strengthens its ADCelerate platform.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
